RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 73 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,558 | +43.4% | 14,939 | +57.6% | 0.00% | – |
| Q1 2024 | $15,733 | +45.1% | 9,478 | +39.9% | 0.00% | – |
| Q4 2023 | $10,840 | -3.7% | 6,775 | +358.4% | 0.00% | – |
| Q3 2023 | $11,255 | +132.2% | 1,478 | +100.0% | 0.00% | – |
| Q2 2023 | $4,848 | +32220.0% | 739 | -70.2% | 0.00% | – |
| Q1 2023 | $15 | +7.1% | 2,476 | -58.2% | 0.00% | -100.0% |
| Q4 2022 | $14 | -99.5% | 5,918 | +359.1% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 1,289 | -86.8% | 0.00% | – |
| Q1 2022 | $29,000 | +163.6% | 9,800 | +691.0% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 1,239 | -4.3% | 0.00% | – |
| Q3 2021 | $10,000 | – | 1,295 | +2843.2% | 0.00% | – |
| Q2 2021 | $0 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $4,054,752 | 14.95% |
| BML Capital Management, LLC | 1,314,229 | $2,102,766 | 1.59% |
| Octagon Capital Advisors LP | 2,250,000 | $3,600,000 | 0.58% |
| NEA Management Company, LLC | 4,785,494 | $7,656,790 | 0.51% |
| TANG CAPITAL MANAGEMENT LLC | 3,330,000 | $5,328,000 | 0.49% |
| Aisling Capital Management LP | 886,075 | $1,417,720 | 0.42% |
| Carlyle Group Inc. | 2,698,957 | $4,318,331 | 0.21% |
| Ikarian Capital, LLC | 1,082,600 | $1,732,160 | 0.16% |
| FIFTH LANE CAPITAL, LP | 40,000 | $64,000 | 0.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,121,704 | $1,794,726 | 0.07% |